Avineuro Pharmaceuticals, Inc. discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry.

Founded in August 2008 and headquartered in San Diego, California Avineuro is managed by professionals experienced in drug discovery and development. By acquiring lead compounds through collaborations and partnerships, Avineuro develops novel products and extends the reach of marketed compounds for indications with a significant commercial potential.

Avineuro emphasizes a rational approach that combines modern medicinal chemistry with streamlined pre-clinical and clinical development studies, thus allowing a fast transition to proof-of-concept product candidates.